GHRP-6

GHRP-6 (Growth Hormone Releasing Peptide-6) is one of the first synthetic growth hormone secretagogues developed, consisting of six amino acids that stimulate growth hormone release through ghrelin receptor (GHS-R1a) activation. Research demonstrates GHRP-6 produces potent GH stimulation but is characterized by significant appetite increase due to its strong ghrelin-mimetic effects. The peptide also elevates cortisol and prolactin levels more than newer, more selective alternatives. Despite these characteristics, GHRP-6 effectively promotes muscle growth, fat metabolism, improved recovery, and enhanced sleep quality through optimized GH secretion. Studies show additive effects when combined with GHRH analogs. GHRP-6 has been used extensively in research settings to study growth hormone physiology and the ghrelin system. The peptide requires multiple daily subcutaneous injections and is typically administered on an empty stomach to maximize GH response. While effective for GH stimulation, the pronounced hunger effects have led many researchers and users to prefer more selective alternatives like Ipamorelin or Hexarelin.

Human data come mainly from short physiological studies of GH secretion, not from trials of therapeutic or performance outcomes. No long-term efficacy or safety trials exist; appetite stimulation, cortisol/prolactin effects, and the need for frequent injections are major caveats.

Short-acting hexapeptide agonist of the ghrelin/GHS-R1a receptor; in research use it is given by subcutaneous injection to stimulate pulsatile GH release. Published human pharmacokinetic data are limited; no approved indication or dose exists.